Recruiting

Prospective Cohort Study of Intracerebral Hemorrhage

The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalised adult patients with intracerebral hemorrhage.

ClinicalTrials.gov IDNCT04707105

PhaseNot Applicable

Enrollment856

SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Intracerebral Hemorrhage

About this study

Primary outcomes

proportion of patients with a 3-month modified Rankin Scale (mRS) score≤ 3 (2-3years)

Eligibility information

Inclusion Criteria: * Hospitalized patients over 18 years old of primary intracerebral hemorrhage. Exclusion Criteria: 1. patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor. 2. isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients； 3. surgical evacuation of hematoma； 4. unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI 5. patients cannot be followed up for any reasons. 6. patients death in 24 hours 7. pregnant patients

Study locations

2nd Affiliated Hospital, School of Medicine at Zhejiang University, Hangzhou, Zhejiang 310000 China

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.